CD8A and cancer: It is now known that CD8+ cytotoxic T cells are the main players driving adaptive immune responses to cancer (37) and that tumors get shielded from immune elimination by decreasing T cell co-stimulation and or expressing ligands that normally interact with inhibitory immune receptors that protect “self” (36).